Skip to Content
ETF News

New ETNs Offer Exposure to M&A, 2x Inverse Treasuries

Van Eck files for two foreign bond ETFs, and the best- and worst-performing ETFs from last week.

Mentioned: , , , , , , , , ,

Large investment banks' interest in offering investors new exchange-traded notes continues unabated, with three new ETNs launched last week that provide exposure to merger and acquisition arbitrage and also to double inverse 10-year and long bond Treasury futures.

With M&A activity heating up, Credit Suisse's new ETN hopes to capitalize on arbitrage opportunities that exist in the markets once deals are announced. The note hopes to take advantage of the spread between the deal price for an acquisition target and that target's (usually discounted) stock price in advance of the deal's closing, which usually reflects uncertainty that the deal actually will close. The uncertainty typically is the result of investor fears that the deal may fall apart for any one of a variety of reasons, including regulator actions, shareholders rejecting the deal, or even financing drying up.

Robert Goldsborough does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.